Top Things to Know

Traditional treatment options (such as surgery) can be very painful, time-consuming and difficult to maintain, and may not be acceptable solutions for millions of patients. In contrast, The Snoring Center delivers state-of-the-art, patient-friendly treatment options marketed directly to consumers. Treatment offerings at The Snoring Center include the proprietary Pillar Procedure (related patents and IP were acquired by The Snoring Center in 2014 from Medtronic), which is a simple procedure performed on over 50,000 patients with no significant adverse effects and a satisfaction rate of over 80%.

The nation's leading provider of minimally invasive treatment for snoring and sleep apnea
2014 revenue of over $3 million; 2015 projected revenue of over $4 million
Featured on Dr. Phil (CBS), The Doctors (CBS) and Good Morning Texas (ABC)

Investment Highlights

IssuerSnoring Center USA, LLC
Type of Offering Texas Intrastate Crowdfunding
Type of SecuritiesTerm Note
Interest Rate 11.98%
Maturity 18 months
Offered ByNextSeed TX LLC

Updates
4

The Snoring Center
Feb 9, 2017

2017 is Looking Great for the Snoring Center

I wanted to give you a quick update on how things are going over at the Snoring Center.

We are doing very well since our raise on NextSeed. We were able to use the funds to increase our sales and marketing efforts, and anticipate adding two new Snoring Center licensees in the next month. We’ve also been able to solidify our relationship with our contract manufacturer by increasing demand for Pillar Palatal implants nationwide.

We are excited to see what the rest of 2017 holds for the Snoring Center!

Thanks for all your support,

Dr. Craig Schwimmer

Issuer Statement

The information contained on this campaign page (the "Campaign Information") is furnished solely by the Issuer to prospective investors in the investment opportunity described herein. All Campaign Information is intended to be a summary of the terms and information contained in the Disclosure Statement and the Note Purchase Agreement, and is fully qualified by reference to those documents. In the event any Campaign Information conflicts with the terms of the Disclosure Statement or Note Purchase Agreement, the terms of those documents will control. The Issuer has provided the Campaign Information for inclusion on the website located at www.nextseed.com, and in no way will the Campaign Information be deemed to have been created or provided by NextSeed Securities, LLC, NextSeed Services, LLC, or their affiliates.